期刊
SCIENCE ADVANCES
卷 6, 期 22, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aaz3865
关键词
-
资金
- NIH [R01CA188419, R01AI070603, P01CA186866]
- American Cancer Society Intra-institutional Grant [129806-IRG16-185-17-IRG]
- Flow Cytometry & Cell Sorting Shared Resource Unit at the OSU and Hollings Cancer Center
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510] Funding Source: NIH RePORTER
Distinct lineages of T cells can act in response to various environmental cues to either drive or restrict immune-mediated pathology. Here, we identify the RNA binding protein, poly(C)-binding protein 1 (PCBP1) as an intracellular immune checkpoint that is up-regulated in activated T cells to prevent conversion of effector T (T-eff) cells into regulatory T (T-reg) cells, by restricting the expression of T-eff cell-intrinsic T-reg commitment programs. This was critical for stabilizing T-eff cell functions and subverting immune-suppressive signals. T cell-specific deletion of Pcbp1 favored T-reg cell differentiation, enlisted multiple inhibitory immune checkpoint molecules including PD-1, TIGIT, and VISTA on tumor-infiltrating lymphocytes, and blunted antitumor immunity. Our results demonstrate a critical role for PCBP1 as an intracellular immune checkpoint for maintaining T-eff cell functions in cancer immunity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据